Chen Jian-Guo, Zhu Jian, Zhang Yong-Hui, Zhang Yi-Xin, Yao Deng-Fu, Chen Yong-Sheng, Lu Jian-Hua, Ding Lu-Lu, Chen Hai-Zhen, Zhu Chao-Yong, Yang Li-Ping, Zhu Yuan-Rong, Qiang Fu-Lin
Qidong Cancer Registry, Qidong Liver Cancer Institute, Qidong, Jiangsu 226200, P.R. China.
Nantong University Tumour Hospital/Institute, Nantong, Jiangsu 226361, P.R. China.
Mol Clin Oncol. 2017 Jun;6(6):944-954. doi: 10.3892/mco.2017.1234. Epub 2017 May 3.
Population-based cancer survival is an improved index for evaluating the overall efficiency of cancer health services in a given region. The current study analysed the observed survival and relative survival of leading cancer sites from a population-based cancer registry between 1972 and 2011 in Qidong, China. A total of 92,780 incident cases with cancer were registered and followed-up for survival status. The main sites of the cancer types, based on the rank order of incidence, were the liver, stomach, lung, colon and rectum, oesophagus, breast, pancreas, leukaemia, brain and central nervous system (B and CNS), bladder, blood [non-Hodgkin's lymphoma (NHL)] and cervix. For all malignancies combined, the 5-year observed survival was 13.18% and the relative survival was 15.80%. Females had higher observed survival and relative survival (19.32 and 22.71%, respectively) compared with males (9.63 and 11.68%, respectively). The cancer sites with the highest five-year relative survival rates were the female breast, bladder, cervix and colon and rectum; followed by NHL, stomach, B and CNS cancer and leukaemia. The poorest survival rates were cancers of oesophagus, lung, pancreas and liver. Higher survival rates were observed in younger patients compared with older patients. Cancers of the oesophagus, female breast and bladder were associated with higher survival in middle-aged groups. Improved survival rates in the most recent two 5-year calendar periods were identified for stomach, lung, colon and rectum, oesophagus, female breast and bladder cancer, as well as leukaemia and NHL. The observations of the current study provide the opportunity for evaluation of the survival outcomes of frequent cancer sites that reflects the changes and improvement in a rural area in China.
基于人群的癌症生存率是评估特定地区癌症医疗服务整体效率的一项改进指标。本研究分析了1972年至2011年中国启东基于人群的癌症登记处主要癌症部位的观察生存率和相对生存率。共登记了92,780例癌症新发病例,并对其生存状况进行了随访。根据发病率排名,癌症类型的主要部位为肝脏、胃、肺、结肠和直肠、食管、乳腺、胰腺、白血病、脑和中枢神经系统(B和CNS)、膀胱、血液[非霍奇金淋巴瘤(NHL)]和子宫颈。对于所有恶性肿瘤合并而言,5年观察生存率为13.18%,相对生存率为15.80%。女性的观察生存率和相对生存率(分别为19.32%和22.71%)高于男性(分别为9.63%和11.68%)。五年相对生存率最高的癌症部位是女性乳腺癌、膀胱癌、子宫颈癌以及结肠和直肠癌;其次是NHL、胃癌、B和CNS癌症以及白血病。生存率最差的是食管癌、肺癌、胰腺癌和肝癌。与老年患者相比,年轻患者的生存率更高。食管癌、女性乳腺癌和膀胱癌在中年组中生存率较高。在最近两个五年日历期内,胃癌、肺癌、结肠和直肠癌、食管癌、女性乳腺癌和膀胱癌以及白血病和NHL的生存率有所提高。本研究的观察结果为评估常见癌症部位的生存结局提供了机会,反映了中国农村地区的变化和改善情况。